Dopamine agonist

Jump to: navigation, search

WikiDoc Resources for Dopamine agonist

Articles

Most recent articles on Dopamine agonist

Most cited articles on Dopamine agonist

Review articles on Dopamine agonist

Articles on Dopamine agonist in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dopamine agonist

Images of Dopamine agonist

Photos of Dopamine agonist

Podcasts & MP3s on Dopamine agonist

Videos on Dopamine agonist

Evidence Based Medicine

Cochrane Collaboration on Dopamine agonist

Bandolier on Dopamine agonist

TRIP on Dopamine agonist

Clinical Trials

Ongoing Trials on Dopamine agonist at Clinical Trials.gov

Trial results on Dopamine agonist

Clinical Trials on Dopamine agonist at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dopamine agonist

NICE Guidance on Dopamine agonist

NHS PRODIGY Guidance

FDA on Dopamine agonist

CDC on Dopamine agonist

Books

Books on Dopamine agonist

News

Dopamine agonist in the news

Be alerted to news on Dopamine agonist

News trends on Dopamine agonist

Commentary

Blogs on Dopamine agonist

Definitions

Definitions of Dopamine agonist

Patient Resources / Community

Patient resources on Dopamine agonist

Discussion groups on Dopamine agonist

Patient Handouts on Dopamine agonist

Directions to Hospitals Treating Dopamine agonist

Risk calculators and risk factors for Dopamine agonist

Healthcare Provider Resources

Symptoms of Dopamine agonist

Causes & Risk Factors for Dopamine agonist

Diagnostic studies for Dopamine agonist

Treatment of Dopamine agonist

Continuing Medical Education (CME)

CME Programs on Dopamine agonist

International

Dopamine agonist en Espanol

Dopamine agonist en Francais

Business

Dopamine agonist in the Marketplace

Patents on Dopamine agonist

Experimental / Informatics

List of terms related to Dopamine agonist

Overview

A dopamine agonist is a compound that activates dopamine receptors, mimicking the effect of the neurotransmitter dopamine.

Uses

Some medical drugs act as dopamine agonists; they are typically used for treating Parkinson's disease, and may be useful for restless legs syndrome (RLS). Both Requip (Ropinirole) and Mirapex (Pramipexole) are FDA approved for the treatment of RLS.

There is also an ongoing clinical trial to test the effectiveness of Requip (Ropinirole), a dopamine agonist, in reversing the symptoms of SSRI induced sexual dysfunction. [1]

Examples

Examples of dopamine agonists include:

See also

References

  1. Clinical trial number NCT00334048 at ClinicalTrials.gov - "Treating Sexual Dysfunction From SSRI Medication: a Study Comparing Requip CR to Placebo"
  2. http://www.fda.gov/bbs/topics/NEWS/2007/NEW01596.html

External links




Linked-in.jpg